Donor | MRD | 30 (28%) | MUD | 31 (29%) | MMRD | 47 (43%) | ||
GvHD prophylaxis | CsA-based | 25 (23%) | Sirolimus-based | 87 (76%) | Other | 1 (1%) | ||
chGvHD type | Classic | 61 (56%) | Overlap | 47 (44%) | ||||
chGvHD grade | Mild | 13 (12%) | Moderate | 39 (36%) | Severe | 56 (52%) | ||
IR score | Low | 38 (35%) | Intermediate | 27 (25%) | High | 28 (26%) | not evaluable | 15 (14%) |
[Table 1. Patients characteristics]